Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes
Researchers at the University of Vermont Cardiovascular Research Institute, Colchester, Vermont have found that increased expression in the heart of plasminogen activator inhibitor type-1 (PAI-1) is profibrotic. The results, ...